Skip to main content
. 2016 Dec 23;64(5):565–571. doi: 10.1093/cid/ciw839

Figure 3.

Figure 3.

Percentage of patients in each creatinine clearance cluster achieving average steady-state plasma concentrations of colistin (Css,avg) of ≥0.5, ≥1, ≥1.5, ≥2, and ≥4 mg/L using the daily dose of colistimethate in Table 3 relevant to the actual creatinine clearance of each patient.